DVA
DaVita Inc.
NYSE Healthcare United States
178,72 $US
+0.02% today
+56.07% YTD · +39.47% 1Y
2
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
17
Hedge funds tracked
Latest available SEC 13F filings
63
/ 100
STRONG

Analysis DaVita Inc. (DVA) — Kairos Score 63/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Key info

👔
CEO
Mr. Javier J. Rodriguez
📍
HQ
2000 16th Street, Denver, CO, 80202, United States
👥
Employees
78 000
💰
Market cap
11 400 422 000,00 $US
📊
P/E
13.5
💸
Dividend yield
—

🕴️ Insider activity (90 days)

2 transactions — 0 buys and 0 sales reported by DaVita Inc. executives.

MD
Maughan David Paul
Chief Operating Officer, DKC · 2026-09-22
Other
HJ
Hollar Jason M.
2026-08-15
Other

🏦 Hedge Funds

17 institutional funds report a position on DVA in their latest SEC quarterly filing.

BERKSHIRE HATHAWAY INC
BlackRock, Inc.
VANGUARD GROUP INC
VANGUARD CAPITAL MANAGEMENT LLC
MORGAN STANLEY

📰 Recent news

15 recent articles on DVA.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as DaVita Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of DVA on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 2 insider transactions over 90 days
✅ All 17 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year